²é¿´: 230  |  »Ø¸´: 0

xiaolu0424

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] ÇóÖú£ºÁ½¾ä»°Ó¢Óï·­Òë³ÉººÓï

¡¡ÒÔÏÂÀ¶É«×ÖÌåµÄÊÇÐèÒª·­ÒëµÄ£¬¹²2¾ä»°£¬Ð»Ð»£¡¡¡
¡¡£¨1£©¡¡Report 127/2002 used a finer dose selection to further investigate effects of roflumilast on preand post-natal development. Female mice (30/dose, NMRI) were given orally 0, 1.5, 3 or 6-mg/kg/day roflumilast during gestation days 6 ¨C 15 and the lactation period. Pregnancy outcomes were examined at delivery. Behavioral developmental effects were evaluated in pups. Doserelated effects on number of stillborns, litter sizes, pup viability and locomotor activity were
observed in the MD and HD groups. The decreases in pup viability were observed both pre and after lactation day 4 (culling).The frequency of litters with live pups at birth, but no pups, on day 4 was 0%, 0%, 0% and 8% in C, LD, MD and HD groups,respectively.The frequency of pup deaths in the post-culling period was 1.1%, 0.3%, 3.2% and 4.5% (p < 0.05) in C, LD, MD and HD groups, respectively. The HD dams showed minimal and statistically non-significant decreases in mean body weight (3.9%).

¡¡¡¡£¨2£©Dose-related decreases in body weight were observed in all treatment groups. Significant, dose-related decreases in prostate weight were noted (down 23.6%, 27.8% and 33.3% compared to control), and HD males showed significant increases in adrenal gland weight. Histopathological findings were noted in the nasal cavity of HD females and in the adrenal cortex in HD males and females. No treatment-related effects on male fertility were observed. Systemic exposure to roflumilast and roflumilast N-oxide increased supra-proportionally to the dose.

[ Last edited by xiaolu0424 on 2011-8-24 at 14:58 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÖÇÄÜ»úÆ÷ÈË

Robot (super robot)

ÎÒÃǶ¼°®Ð¡Ä¾³æ

ÕÒµ½Ò»Ð©Ïà¹ØµÄ¾«»ªÌû×Ó£¬Ï£ÍûÓÐÓÃŶ~

¿ÆÑдÓСľ³æ¿ªÊ¼£¬ÈËÈËΪÎÒ£¬ÎÒΪÈËÈË
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ xiaolu0424 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[˶²©¼ÒÔ°] ÉîÛÚ´óѧ˶ʿÕÐÉú£¨2026Ç´«¸ÐÆ÷·½Ïò£¬½ö¼ȡµÚÒ»Ö¾Ô¸£© +4 xujiaoszu 2026-03-11 10/500 2026-03-18 08:50 by xujiaoszu
[¿¼ÑÐ] ¿¼ÑÐÇóµ÷¼Á +3 éÙËÌ. 2026-03-17 4/200 2026-03-17 21:43 by ÓÐÖ»ÀêÅ«
[¿¼ÑÐ] 070300»¯Ñ§319Çóµ÷¼Á +4 ½õÀð0909 2026-03-17 4/200 2026-03-17 18:21 by ÖØ¿ÆÐ¡°ÔÍõ
[˶²©¼ÒÔ°] ºþ±±¹¤Òµ´óѧ ÉúÃü¿ÆÑ§Ó뽡¿µÑ§Ôº-¿ÎÌâ×éÕÐÊÕ2026¼¶Ê³Æ·/ÉúÎï·½Ïò˶ʿ +3 1ϲ´º8 2026-03-17 5/250 2026-03-17 17:18 by ber´¨cool×Ó
[¿¼ÑÐ] 0854¿É¿çµ÷¼Á£¬Ò»×÷Ò»ÏîºËÐÄÂÛÎÄÎåÏîרÀû£¬Ê¡¡¢¹ú¼¶Ö¤Êé40+ÊýÒ»Ó¢Ò»287 +3 СÀî0854 2026-03-16 3/150 2026-03-17 13:40 by ÈÈÇéɳĮ
[¿¼ÑÐ] 286Çóµ÷¼Á +3 lemonzzn 2026-03-16 5/250 2026-03-16 20:43 by lemonzzn
[¿¼ÑÐ] Ò»Ö¾Ô¸985£¬±¾¿Æ211£¬0817»¯Ñ§¹¤³ÌÓë¼¼Êõ319Çóµ÷¼Á +5 Liwangman 2026-03-15 5/250 2026-03-16 17:10 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 0703 ÎïÀí»¯Ñ§µ÷¼Á +3 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-13 5/250 2026-03-16 10:50 by ÎÒ¿ÉÒÔÉϰ¶µÄ¶ÔÂ
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 ºôºô£¿~+123456 2026-03-14 3/150 2026-03-14 16:53 by WTUChen
[¿¼ÑÐ] 331Çóµ÷¼Á£¨0703Óлú»¯Ñ§ +5 ZY-05 2026-03-13 6/300 2026-03-14 10:51 by Jy?
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-03-13 4/200 2026-03-14 08:37 by zhukairuo
[¿¼ÑÐ] 0703£¬333·ÖÇóµ÷¼Á Ò»Ö¾Ô¸Ö£ÖÝ´óѧ-ÎïÀí»¯Ñ§ +3 Àîħٶ·Åñ 2026-03-11 3/150 2026-03-13 22:24 by JourneyLucky
[¿¼ÑÐ] 290Çóµ÷¼Á +9 ADT 2026-03-11 9/450 2026-03-13 21:55 by JourneyLucky
[¿¼ÑÐ] 304Çóµ÷¼Á +7 7712b 2026-03-13 7/350 2026-03-13 21:42 by peike
[¿¼ÑÐ] ¹¤¿Æ£¬Çóµ÷¼Á +3 ÎÒ887 2026-03-11 3/150 2026-03-13 21:39 by JourneyLucky
[¿¼ÑÐ] ²ÄÁϹ¤³Ìµ÷¼Á +4 ßäßä¿Õ¿Õ 2026-03-11 4/200 2026-03-13 19:57 by JourneyLucky
[¿¼ÑÐ] Çóµ÷¼Á +5 Ò»¶¨ÓÐѧÉÏ- 2026-03-12 5/250 2026-03-13 18:31 by ms629
[¿¼ÑÐ] ¹¤¿Æµ÷¼Á +4 Jiang191123£¡ 2026-03-11 4/200 2026-03-13 15:15 by Miko19
[¿¼ÑÐ] Çóµ÷¼Á +3 ³ÌÓ꺼 2026-03-12 3/150 2026-03-13 15:06 by JourneyLucky
[¿¼²©] 2026Ä격ʿÉêÇë +3 QwQwQW10 2026-03-11 3/150 2026-03-12 17:58 by gxch43
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û